Haematologica (Aug 2012)
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
- Ygal Benhamou,
- Cyrielle Assié,
- Pierre-Yves Boelle,
- Marc Buffet,
- Rana Grillberger,
- Sandrine Malot,
- Alain Wynckel,
- Claire Presne,
- Gabriel Choukroun,
- Pascale Poullin,
- François Provôt,
- Didier Gruson,
- Mohamed Hamidou,
- Dominique Bordessoule,
- Jacques Pourrat,
- Jean-Paul Mira,
- Véronique Le Guern,
- Claire Pouteil-Noble,
- Cédric Daubin,
- Philippe Vanhille,
- Eric Rondeau,
- Jean-Bernard Palcoux,
- Christiane Mousson,
- Cécile Vigneau,
- Guy Bonmarchand,
- Bertrand Guidet,
- Lionel Galicier,
- Elie Azoulay,
- Hanspeter Rottensteiner,
- Agnès Veyradier,
- Paul Coppo
Affiliations
- Ygal Benhamou
- Cyrielle Assié
- Pierre-Yves Boelle
- Marc Buffet
- Rana Grillberger
- Sandrine Malot
- Alain Wynckel
- Claire Presne
- Gabriel Choukroun
- Pascale Poullin
- François Provôt
- Didier Gruson
- Mohamed Hamidou
- Dominique Bordessoule
- Jacques Pourrat
- Jean-Paul Mira
- Véronique Le Guern
- Claire Pouteil-Noble
- Cédric Daubin
- Philippe Vanhille
- Eric Rondeau
- Jean-Bernard Palcoux
- Christiane Mousson
- Cécile Vigneau
- Guy Bonmarchand
- Bertrand Guidet
- Lionel Galicier
- Elie Azoulay
- Hanspeter Rottensteiner
- Agnès Veyradier
- Paul Coppo
- DOI
- https://doi.org/10.3324/haematol.2011.049676
- Journal volume & issue
-
Vol. 97,
no. 8
Abstract
Background Acquired thrombotic thrombocytopenic purpura is still associated with a 10–20% death rate. It has still not been possible to clearly identify early prognostic factors of death. This study involved thrombotic thrombocytopenic purpura patients with acquired severe (
